80.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
Summit Creek Advisors LLC Buys New Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Bank of America Corp DE Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Rice Hall James & Associates LLC Purchases Shares of 189,907 LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT Q2 2026 Earnings: EPS Misses Estimates as Stock Holds Modest DeclinePre-Earnings Setup - vinanet.vn
LeMaitre Vascular (LMAT) Edges Higher to $82.38, Holding Ground Above Key SupportMean Reversion Trade - vinanet.vn
LeMaitre Vascular (LMAT) Advances Modestly to $82.38 as Range-Bound Trading PersistsDaily Profile - dars.gov.et
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular (LMAT) Holds Steady Near $82 as Medtech Sector Shows ResilienceVolume Nodes - Vinanet
How Investors May Respond To LeMaitre Vascular (LMAT) Trimmed 2026 Outlook Despite Higher Q2 Sales - simplywall.st
Price performance - Yahoo Finance Australia
LeMaitre Vascular remains a Buy despite 31% pul... - Pluang
LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT) - Seeking Alpha
The Technical Signals Behind (LMAT) That Institutions Follow - Stock Traders Daily
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 39% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call - The Globe and Mail
Quantinno Capital Management LP Buys 18,204 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Has A Fresh Update, So Why Is It Drawing Attention? - Sahm
31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update - Yahoo Finance
LeMaitre Vascular, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - simplywall.st
LeMaitre Vascular (LMAT) Hit by Profit Taking - AlphaStreet
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - The Manila Times
LeMaitre management to meet investors at virtual Aug. 11 event - Stock Titan
LeMaitre Vascular sales increase 10% to USD 70.4M in Q2 2026 - Medical Buyer
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95 - Yahoo Finance
Stocks making big moves yesterday: LeMaitre, ePlus, Booking, Paymentus, and Vishay Intertechnology - theglobeandmail.com
LMAT SWOT Analysis: Strong Financial Growth and Market Position Revealed in 10-Q Filing - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year Low on Analyst Downgrade - MarketBeat
LeMaitre Vascular stock hits 52-week low at 79.38 USD By Investing.com - Investing.com Nigeria
LeMaitre Vascular stock hits 52-week low at 79.38 USD - Investing.com
LeMaitre Vascular Down Over 22%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk - Moomoo
LMAT Looks 15.2% Undervalued on GF Value™ Despite Recent Sharp P - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Cut to $94.00 by Analysts at Wells Fargo & Company - MarketBeat
Why LeMaitre (LMAT) Shares Are Getting Obliterated Today - TradingView
Why is LeMaitre Vascular stock tumbling today? By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down on Disappointing Earnings - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research - MarketBeat
LeMaitre Vascular, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform - Yahoo Finance
Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside - TradingView
LeMaitre Vascular Announces Q2 2026 Earnings with Increased Sales and Net Income - Kalkine Media
LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ... - Yahoo Finance
LEMAITRE VASCULAR, INC. : BARRINGTON RESEARCH CUTS TO MARKET PERFORM FROM OUTPERFORM - Bitget
LeMaitre Vascular Q2 Earnings Call Highlights - MarketBeat
Is LeMaitre Vascular Inc (LMAT) Overvalued After Q2 Earnings Mis - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results - marketbeat.com
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates - finance.yahoo.com
LeMaitre Vascular (NASDAQ:LMAT) Releases Q4 2026 Earnings Guidance - MarketBeat
Earnings call transcript: LeMaitre Vascular slips on Q2 2026 miss, cuts outlook - Investing.com
GUIDANCE: (LMAT) LeMaitre Vascular Expects Full Year 2026 EPS Range $2.84$2.94, Vs. FactSet Est of $3.00 - Moomoo
LeMaitre Vascular Inc reports results for the quarter ended June 30Earnings Summary - TradingView
LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6% - Yahoo Finance
Q2 2026 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2026 Earnings Guidance - MarketBeat
LeMaitre Q2 2026 sales rise 10 percent to $70.4 million - Quiver Quantitative
LeMaitre: Q2 Earnings Snapshot - KHOU
LeMaitre Vascular Q2 sales slightly miss estimates - TradingView
LeMaitre Q2 2026 Financial Results - The Manila Times
BRIEF-LeMaitre Vascular Q2 Sales USD 70.382 Million Vs. IBES Estimate USD 71 Million - TradingView
LeMaitre says Artegraft is now approved in 56 countries - stocktitan.net
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):